Track OptimizeRx Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

OptimizeRx Corporation OPRX · Stock Open OptimizeRx Corporation in new tab

6.63 USD
P/E
27.21
EPS
0.26
P/B
1.00
ROE
3.92
Beta
1.15
Target Price
11.90 USD
OptimizeRx Corporation logo

OptimizeRx Corporation

🧾 Earnings Recap – Q2 2026

Shares surged 26.9% following Q2 results that beat revenue and adjusted EBITDA expectations, driven by ongoing margin expansion and strong commercial momentum in AI-enabled offerings and platform innovation.

  • Q2 revenue reached $20.5 million with adjusted EBITDA of $4.9 million, both surpassing consensus estimates.
  • Despite some revenue declines from a few large customers transitioning away from lower-margin services, growth was evident across the broader business.
  • AI-enabled software subscriptions grew 25% year-over-year, underscoring a successful shift toward recurring revenue models.
  • Three new product launches, including integration with DeepIntent’s DSP and the AI-powered natural language audience builder, bolster the company’s competitive position.
  • Reiteration of full-year 2026 guidance ($95–100 million revenue; $21–25 million adjusted EBITDA) reflects confidence despite some near-term revenue variability.
📅
Loading chart...
Key Metrics
Earnings dateMarch 4, 2027
P/E27.21
EPS0.26
Book Value7.08
Price to Book1.00
Debt/Equity9.82
% Insiders13.769%
Growth
Revenue Growth-0.17%
Earnings Growth0.50%
Estimates
Forward P/E6.73
Forward EPS1.05
Target Mean Price11.90

DCF valuation

Model fair value for OptimizeRx Corporation (OPRX)
Result
Sign in to run the valuation for OPRX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
5 analysts · consensus Strong buy · mean target 11.90 USD (low 10.00, high 18.00) · as of 19 Nov 2026
Low 10.00
Mean 11.90
High 18.00
Price 6.63
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

OptimizeRx Corporation Logo OptimizeRx Corporation Analysis (OPRX)

United States Health Care Official Website Stock

Is OptimizeRx Corporation a good investment? OptimizeRx Corporation (OPRX) is currently trading at 6.63 USD. Market analysts have a consensus price target of 11.90 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 27.21. This valuation is generally in line with the broader market.

Earnings Schedule: OptimizeRx Corporation is expected to release its next earnings report on March 4, 2027. The market consensus estimate for Forward EPS is 1.05.

Investor FAQ

Does OptimizeRx Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is OptimizeRx Corporation?

OptimizeRx Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 4, 2027. The company currently has a trailing EPS of 0.26.

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
NCM (Australia) OPRX
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 14, 2018 0.33
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion